000 00986 a2200277 4500
005 20250518041351.0
008 ####s 0 0 eng d
022 _a1734-1922
024 7 _a10.5114/aoms.2018.76141
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLi, Kun-Peng
245 0 0 _aFull dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in China.
_h[electronic resource]
260 _bArchives of medical science : AMS
_cMay 2019
300 _a700-705 p.
_bdigital
500 _aPublication Type: Journal Article
700 1 _aJin, Jing-Yu
700 1 _aYang, Jin-Shui
700 1 _aLi, Yan
700 1 _aZhao, Wei
700 1 _aLuo, Gui
700 1 _aZhu, Jian
700 1 _aZhang, Jiang-Lin
700 1 _aHuang, Feng
773 0 _tArchives of medical science : AMS
_gvol. 15
_gno. 3
_gp. 700-705
856 4 0 _uhttps://doi.org/10.5114/aoms.2018.76141
_zAvailable from publisher's website
999 _c29711661
_d29711661